Clinical trials recruiting for PET / CT
9
Recruiting trials
0
US states with sites
2
Countries
11%
Accept healthy volunteers
Phase breakdown
Early Phase 1 1Not applicable 8
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| [18F]AlF-PSMA-N5 | 1 |
| [18F]F-DCFPyL | 1 |
Self-screener
Recruiting trials
- 68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer
- 68Ga-XACP3 PET/CT in Prostate Cancer
- 68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.
- Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors
- DLL3-Targeted PET/CT in Small Cell Lung Cancer
- FAP-targeted PET/NIR in Lung Malignant Tumors
- Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis
- PET/CT for Trop2 ADC Response Evaluation Cancers
- PROMISE PET Registry on PSMA-PET and Outcome in Prostate Cancer
Related conditions
Trials recruiting for PET / CT often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Prostate cancer 1234Non-small cell lung cancer 507Breast cancer 2239Survivorship 12Small Cell Lung Cancer ( SCLC ) 29Pulmonary Nodules 6Neoadjuvant Therapy 23Malignant Neoplasm 13Lung Carcinoma 30
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for PET / CT trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.